USFDA accepted the Roche’s sBLA for Tecentriq (atezolizumab) in combination with Abraxane
Posted on30 Jan 2019
Comments0
US Food and Drug Administration (FDA) has accepted the Roche’s supplemental Biologics License Application (sBLA) for Tecentriq® (atezolizumab) in combination with Abraxane®... Read More